Table 4.
Outcomes of EUS-RV.
| DEHBD/D2 Route | PEHBD/D1 Route | LIHBD/S Route | RIHBD/D1 Route | p | |
|---|---|---|---|---|---|
| (n = 10) | (n = 5) | (n = 1) | (n = 1) * | ||
| Successful biliary puncture, n (%) | 10 (100) | 4 (80) | 1 (100) | 1 (100) | 0.412 |
| Successful GW placement, n (%) | 10 (100) | 4 (80) | 1 (100) | 1 (100) | 0.412 |
| Successful cannulation, n (%) | 10 (100) | 4 (80) | 1 (100) | 1 (100) | 0.412 |
| Conversion to the other route, n (%) | 0 | 1 (20) | 0 | 0 | 0.412 |
| Final biliary cannulation, n (%) | 10 (100) | 5 (100) | 1 (100) | - | 1 |
| Time from echoendoscope insertion to cannulation (range), min | 31 (15–48) | 37 (34–45) | 45 | 45 | 0.199 |
| Adverse events, n (%) | 0 | 1 (20) | 0 | 0 | 0.412 |
| Adverse events | - | moderate pancreatitis | - | - |
* Conversion from the PEHBD/D1 route. EUS-RV: endoscopic ultrasound-guided rendezvous; DEHBD/D2: distal extrahepatic bile duct/duodenal second part; PEHBD/D1: proximal extrahepatic bile duct/duodenal bulb; LIHBD/S: left intrahepatic bile duct/stomach; RIHBD/D1: right intrahepatic bile duct/duodenal bulb; GW: guidewire.